These sources consist of legitimate science or are evidence-based through credible scientific sourcing. Legitimate science follows the scientific method, is unbiased, and does not use emotional words. These sources also respect the consensus of experts in the given scientific field and strive to publish peer-reviewed science. Some sources in this category may have a slight political bias but adhere to scientific principles. See all Pro-Science sources.
- Overall, we rate Cancer Cell International as a Pro-Science open-source journal. We also rate them High for factual reporting due to a clean fact check record.
Bias Rating: PRO-SCIENCE
Factual Reporting: HIGH
Country: United Kingdom
MBFC’s Country Freedom Rank: MOSTLY FREE
Media Type: Organization/Foundation
Traffic/Popularity: Minimal Traffic
MBFC Credibility Rating: HIGH CREDIBILITY
Cancer Cell International is a peer-reviewed open-access journal published by BioMed Central (BMC) covering cancer cell biology. According to its about page, “Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation.”
Founded in 2000, BioMed Central, or BMC, is a United Kingdom-based, for-profit scientific open-access publisher. They publish more than 300 journals that are entirely online. According to their about page, “Our leading research journals include selective titles such as BMC Biology, BMC Medicine, Genome Biology and Genome Medicine, academic journals such as Journal of Hematology & Oncology, Malaria Journal, and Microbiome, and the BMC series, 65 inclusive journals focused on the needs of individual research communities. We also partner with leading institutions and societies to publish journals on their behalf.”
Funded by / Ownership
BioMed Central is owned by Springer Nature, an academic publishing company created by the May 2015 merger of Springer Science+Business Media and Holtzbrinck Publishing Group’s Nature Publishing Group, Palgrave Macmillan, and Macmillan Education. The company reported revenues of over 1 billion USD.
Analysis / Bias
Cancer Cell International is an open-access journal that publishes information and research related to cancer cell biology. The journal primarily publishes research like this Antiproliferative and apoptotic effects of telmisartan in human glioma cells.
BioMed Central (BMC) is an open-access publisher of scientific journals. There are two types of Open Access Journals, legitimate and predatory, both of which charge the author for publication. Predatory journals often lack peer review and are generally considered not credible. BioMed Central is considered a legitimate, open-access publisher that is frequently indexed in PubMed. However, BMC journals have been criticized for retracting numerous studies due to fake peer reviews or poor methodology.
Although BMC has retracted some studies in other publications that were found to be of poor methodology and not thoroughly peer-reviewed, Cancer Cell International publishes credible scientific studies that are factual and appropriately peer-reviewed.
Failed Fact Checks
- None by Cancer Cell International; however, BioMed Central has.
Overall, we rate Cancer Cell International as a Pro-Science open-source journal. We also rate them High for factual reporting due to a clean fact check record. (D. Van Zandt 06/23/2023)